Photo by Chip Somodevilla/Getty Images Novo Nordisk A/S Chief Executive Officer Lars Fruergaard Jorgensen found himself struggling to defend the price of blockbuster drugs Ozempic and Wegovy in a ...
Lars Fruergaard Jørgensen, Novo Nordisk's CEO, says his company is working to expand manufacturing to meet the supply ...
Sitting in front of a chart showing the lower prices for Wegovy and Ozempic in other countries, Sen. Bernie Sanders, ...
Ozempic is a popular diabetes drug that is also used for weight loss by suppressing appetite. Sanders expressed confidence ...
Ozempic and Wegovy are making so much money for Novo Nordisk A/S that their cumulative sales will soon surpass the ...
Americans are paying more than $900 a month for popular weight-loss drugs Ozempic and Wegovy, but drugmakers want to sell ...